SG48784A1 - Use of tetrahydropyridine derivatives for the preparation of cardioprotective medicaments - Google Patents

Use of tetrahydropyridine derivatives for the preparation of cardioprotective medicaments

Info

Publication number: SG48784A1
Authority: SG; Singapore
Prior art keywords: cardioprotective; medicaments; preparation; tetrahydropyridine derivatives; tetrahydropyridine
Prior art date: 1993-03-18

Application number

SG1996001628A

Other languages

English (en)

Inventor

Allan Stewart Manning

Pierre Paul Chatelain

Original Assignee

Sanofi Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-03-18

Filing date

1994-03-18

Publication date

1998-05-18

1994-03-18 Application filed by Sanofi Sa filed Critical Sanofi Sa

1998-05-18 Publication of SG48784A1 publication Critical patent/SG48784A1/en

Links

230000003293 cardioprotective effect Effects 0.000 title abstract 2
239000003814 drug Substances 0.000 title abstract 2
VSWICNJIUPRZIK-UHFFFAOYSA-N 2-piperideine Chemical class C1CNC=CC1 VSWICNJIUPRZIK-UHFFFAOYSA-N 0.000 title 1
125000004924 2-naphthylethyl group Chemical group C1=C(C=CC2=CC=CC=C12)CC* 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
150000007513 acids Chemical class 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Heart & Thoracic Surgery (AREA)
General Chemical & Material Sciences (AREA)
Cardiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Hydrogenated Pyridines (AREA)

SG1996001628A 1993-03-18 1994-03-18 Use of tetrahydropyridine derivatives for the preparation of cardioprotective medicaments SG48784A1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9303149A FR2702656B1 (fr)	1993-03-18	1993-03-18	Utilisation de derives de la tetrahydropyridine pour la preparation de medicaments cardioprotecteurs.

Publications (1)

Publication Number	Publication Date
SG48784A1 true SG48784A1 (en)	1998-05-18

Family

ID=9445120

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SG1996001628A SG48784A1 (en)	1993-03-18	1994-03-18	Use of tetrahydropyridine derivatives for the preparation of cardioprotective medicaments

Country Status (9)

Country	Link
US (1)	US5378709A (de)
EP (1)	EP0615755B1 (de)
JP (1)	JP2650847B2 (de)
AT (1)	ATE230991T1 (de)
DE (1)	DE69432000T2 (de)
DK (1)	DK0615755T3 (de)
ES (1)	ES2191022T3 (de)
FR (1)	FR2702656B1 (de)
SG (1)	SG48784A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5891465A (en) *	1996-05-14	1999-04-06	Biozone Laboratories, Inc.	Delivery of biologically active material in a liposomal formulation for administration into the mouth
FR2772614B1 (fr) *	1997-12-24	2000-03-10	Sanofi Sa	Solution aqueuse a base de chlorhydrate de 1- [ 2-(2-naphtyl)ethyl]-4- (3-trifluoromethylphenyl) -1,2,3,6-tetrahydropyridine et composition pharmaceutique buvable en contenant
CZ20031262A3 (en) *	2000-10-16	2004-03-17	Neopharm, Inc.	Liposomal formulation of mitoxantrone
US20090076048A1 (en) *	2007-09-19	2009-03-19	Protia, Llc	Deuterium-enriched xaliproden

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2639226B1 (fr) *	1988-11-18	1993-11-05	Sanofi	Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles anxio-depressifs
FR2650505B1 (fr) *	1989-08-07	1994-06-03	Midy Spa	Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles de la motricite intestinale
GB8919661D0 (en) *	1989-08-31	1989-10-11	Univ Alberta	Superoxide dismutase-catalase conjugates
FR2662355B1 (fr) *	1990-05-22	1994-11-10	Sanofi Sa	Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
FR2672213B1 (fr) *	1991-02-05	1995-03-10	Sanofi Sa	Utilisation de derives 4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridiniques comme capteurs de radicaux libres.

1993
- 1993-03-18 FR FR9303149A patent/FR2702656B1/fr not_active Expired - Fee Related
1994
- 1994-03-17 JP JP6047391A patent/JP2650847B2/ja not_active Expired - Fee Related
- 1994-03-17 US US08/214,307 patent/US5378709A/en not_active Expired - Lifetime
- 1994-03-18 AT AT94400597T patent/ATE230991T1/de not_active IP Right Cessation
- 1994-03-18 ES ES94400597T patent/ES2191022T3/es not_active Expired - Lifetime
- 1994-03-18 SG SG1996001628A patent/SG48784A1/en unknown
- 1994-03-18 EP EP94400597A patent/EP0615755B1/de not_active Expired - Lifetime
- 1994-03-18 DK DK94400597T patent/DK0615755T3/da active
- 1994-03-18 DE DE69432000T patent/DE69432000T2/de not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP0615755A1 (de)	1994-09-21
EP0615755B1 (de)	2003-01-15
ATE230991T1 (de)	2003-02-15
US5378709A (en)	1995-01-03
JPH06340628A (ja)	1994-12-13
DE69432000D1 (de)	2003-02-20
DK0615755T3 (da)	2003-03-17
ES2191022T3 (es)	2003-09-01
FR2702656B1 (fr)	1995-06-16
FR2702656A1 (fr)	1994-09-23
JP2650847B2 (ja)	1997-09-10
DE69432000T2 (de)	2003-09-04

Similar Documents

Publication	Publication Date	Title
AU589029B2 (en)	1989-09-28	Alpha-alkyl-4-amino-3-quinolinemethanols and 1-(4-aralkylamino-3-quinolinyl) alkanones, a process for their preparation and their use as medicaments
KR0156747B1 (en)	1998-11-16	Use of 1,3-oxathiolan nucleoside analogues in the treatment of hepatitis-b
YU87589A (en)	1990-12-31	Optically active derivatives of pyrodoncarboxylic acid
ZA932168B (en)	1993-11-08	Naphthylalkylamines, process for preparing them and pharmaceutical compositions containing them
IL88755A (en)	1993-01-31	(1:, 2, 3:)-3-substituted-2- hydroxycyclo- butanemethanol derivatives and pharmaceutical and veterinary compositions containing the same
GR3018086T3 (en)	1996-02-29	Heterocyclic bisphosphonic acid derivatives.
IL90271A0 (en)	1989-12-15	Antiviral drug
NZ238516A (en)	1993-09-27	Hexahydroazepine derivatives; preparatory processes and pharmaceutical compositions
IL88742A (en)	1993-08-18	Hiv inhibiting compositions containing polyhydroxy derivatives of pyrrolidine and certain novel derivatives thereof
AU656674B2 (en)	1995-02-09	New thiochroman compounds, processes for the preparation thereof, and pharmaceutical compositions containing them
AU4746993A (en)	1993-12-02	Azetidine compounds
DK0615755T3 (da)	2003-03-17	Anvendelse af tetrahydropyridinderivater til fremstilling af cardiobeskyttende lægemidler
ZA935866B (en)	1994-03-09	New 17-hydroxyiminomethyl-5B 14 B-androstane derivatives active on the cardiovascular system processes for their preparation and pharmaceutical compositions containing same
MY108303A (en)	1996-09-30	Neuroleptic 2-substituted perhydro-1-h-pyrido [1,2-a]pyrazines.
EP0855398A4 (de)	2000-03-22	Sesquiterpen-derivate mit antivitaler aktivität
TW344743B (en)	1998-11-11	Therapeutic nucleosides
AU668398B2 (en)	1996-05-02	New aminoalkylchromones, processes for the preparation thereof, and pharmaceutical compositions containing them
AU6231090A (en)	1991-03-14	N-azabicyclo(3.3.0)octane amides of aromatic acids
ZA941056B (en)	1994-08-29	(Cyclohexyl)alkene compounds processes for preparing them and pharmaceutical compositions containing them
HU9202484D0 (en)	1992-10-28	Method for producing medical preparatives containing 1,4-dihydro-pyridine derivatives
ZA933942B (en)	1993-12-30	Pyrrolothienopyrazine compounds, processes for the preparation thereof and pharmaceutical compositions containing them
DE59201085D1 (de)	1995-02-09	Neue p-Oxibenzoesäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel.